The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Blood-brain barrier regulation in psychiatric disorders
Open accessAbstract
The blood-brain barrier (BBB) is a dynamic interface between the peripheral blood supply and the cerebral parenchyma, controlling the transport of material to and from the brain. Tight junctions between the endothelial cells of the cerebral microvasculature limit the passage of large, negatively charged molecules via paracellular diffusion whereas transcellular transportation across the endothelial cell is controlled by a number of mechanisms including transporter proteins, endocytosis, and diffusion. Here, we review the evidence that perturbation of these processes may underlie the development of psychiatric disorders including schizophrenia, autism spectrum disorder (ASD), and affective disorders. Increased permeability of the BBB appears to be a common factor in these disorders, leading to increased infiltration of peripheral material into the brain culminating in neuroinflammation and oxidative stress. However, although there is no common mechanism underpinning BBB dysfunction even within each particular disorder, the tight junction protein claudin-5 may be a clinically relevant target given that both clinical and pre-clinical research has linked it to schizophrenia, ASD, and depression. Additionally, we discuss the clinical significance of the BBB in diagnosis (genetic markers, dynamic contrast-enhanced-magnetic resonance imaging, and blood biomarkers) and in treatment (drug delivery).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–256 of 256
Current and emerging brain applications of MR-guided focused ultrasound
Meng, Y., Suppiah, S., Mithani, K., Solomon, B., Schwartz, M. L., & Lipsman, N. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0105-z · Cited by 65
McCullumsmith, R. E., O'Donovan, S. M., Drummond, J. B., Benesh, F., Simmons, M. S., Roberts, R. C., Lauriat, T. L., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.148 · Cited by 64
Folate Receptor Autoantibodies and Spinal Fluid 5-Methyltetrahydrofolate Deficiency in Rett Syndrome
Ramaekers, V. T., Sequeira, J. M., Artuch, R., et al. (2007) · Neuropediatrics · doi:10.1055/s-2007-991148 · Cited by 63
Gülöksüz, S. A., Abalı, O., Çetin, E. A., Gazioglu, S. B., Deniz, G., Yildirim, A., Kawiková, I., Gülöksüz, S., & Leckman, J. F. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1843 · Cited by 63
Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia
Vm, V., Orlovskaya, D. D., & Uranova, N. A. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701210247 · Cited by 62
PKA activation and endothelial claudin-5 breakdown in the schizophrenic prefrontal cortex
Nishiura, K., Ichikawa‐Tomikawa, N., Sugimoto, K., Kunii, Y., Kashiwagi, K., Tanaka, M., Yokoyama, Y., Hino, M., Sugino, T., Yabe, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21850 · Cited by 62
Breitenstein, B., Scheuer, S., Brückl, T. M., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.11.010 · Cited by 61
Jiao, X., He, P., Li, Y., Fan, Z., Si, M., Xie, Q., Chang, X., & Huang, D. (2015) · Disease Markers · doi:10.1155/2015/860120 · Cited by 58
Stress does not increase blood–brain barrier permeability in mice
Roszkowski, M., & Bohacek, J. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16647739 · Cited by 56
Lekakis, J. P., Ikonomidis, I., Papoutsi, Z., Moutsatsou, P., Nikolaou, M., Parissis, J., & Kremastinos, D. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.010 · Cited by 55
Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid
Ferrarese, C., Pecora, N., Frigo, M., Appollobnio, I., & Frattola, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330316 · Cited by 55
O'Brien, F., Clarke, G. A., Fitzgerald, P., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01858.x · Cited by 52
Zhang, B., Guan, F., Chen, G., Lin, H., Zhang, T., Feng, J., Li, L., & Fu, D. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.012 · Cited by 52
Özbey, G., Yucel, B., Taycan, S. E., Kan, D., Bodur, N. E., Arslan, T., Perçin, E. F., Yüksel, N., Güzey, C., & Uluoğlu, C. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.09.004 · Cited by 51
ABCB1 Genotyping in the Treatment of Depression
Brückl, T. M., & Uhr, M. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.18 · Cited by 49
Ghassemifar, R., Sheth, B., Papenbrock, T., Leese, H. J., Houghton, F. D., & Fleming, T. P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3171 · Cited by 48
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
Stroth, N., & Svenningsson, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.003 · Cited by 46
Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT).
Sharma, H. S., & Dey, P. (1981) · PubMed · Cited by 46
VEGF-related polymorphisms identified by GWAS and risk for major depression
Xie, T., Stathopoulou, M. G., de Andrés, F., Siest, G., Murray, H. A., Martin, M., Cobaleda, J., Delgado, A., Lamont, J. V., Peñas-LIedó, E., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.36 · Cited by 46
Hua, J., Brandt, A. S., Lee, S. W., Blair, N. I. S., Wu, Y., Lui, S., Patel, J., Faria, A. V., Lim, I. A. L., Unschuld, P. G., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw109 · Cited by 44
Cohen, B. M., Yurgelun-Todd, D. A., English, C. D., & Renshaw, P. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1801 · Cited by 43
MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression
Lee, S. H., Lee, M., Lee, J. H., Kim, S. W., Kang, R.-H., Choi, M.-J., Park, S. J., Kim, S. J., Lee, J. M., Cole, S. P. C., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181d2ef42 · Cited by 42
Lee, B.-H., Hong, J.-P., Hwang, J.-A., Ham, B., Na, K., Kim, W.-J., Trigo, J., & Kim, Y. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.020 · Cited by 42
O’Keeffe, E., & Campbell, M. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.008 · Cited by 42
Self-citationTsuchiya, K. J., Hashimoto, K., Iwata, Y., Tsujii, M., Sekine, Y., Sugihara, G., Matsuzaki, H., Suda, S., Kawai, M., Nakamura, K., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.018 · Cited by 41
Strategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling
Wager, T. T., Liras, J. L., Mente, S., & Trapa, P. E. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677028 · Cited by 38
Shimada, A., & Hasegawa‐Ishii, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00017 · Cited by 38
Esnafoğlu, E., Ayyıldız, S. N., Cırrık, S., Ertürk, E. Y., Erdil, A., Dağlı, A., & Noyan, T. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.06.011 · Cited by 38
Tight junction targeting and intracellular trafficking of occludin in polarized epithelial cells
Subramanian, V. S., Marchant, J. S., Ye, D., Ma, T. Y., & Said, H. M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00309.2007 · Cited by 37
Chen, S., Tian, L., Chen, N., Xiu, M., Wang, Z., Yang, G., Wang, C., Yang, F., & Tan, Y. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.09.029 · Cited by 37
Cerebrovascular heterogeneity and neuronal excitability
Librizzi, L., de Cutis, M., Janigro, D., Runtz, L., de Bock, F., Barbier, E., & Marchi, N. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.013 · Cited by 37
Hierarchical cortical transcriptome disorganization in autism
Lombardo, M. V., Courchesne, E., Lewis, N. E., & Pramparo, T. (2017) · Molecular Autism · doi:10.1186/s13229-017-0147-7 · Cited by 36
Miguel-Hidalgo, J. J., Overholser, J. C., Jurjus, G., Meltzer, H. Y., Dieter, L., Konick, L. C., Stockmeier, C. A., & Rajkowska, G. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.052 · Cited by 35
Busse, M., Kunschmann, R., Dobrowolny, H., Hoffmann, J., Bogerts, B., Steiner, J., Frodl, T., & Busse, S. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0768-z · Cited by 35
de Klerk, O. L., Bosker, F. J., Willemsen, A. T. M., van Waarde, A., Visser, A. K. D., de Jager, T., Dagytė, G., den Boer, J. A., Dierckx, R., & Meerlo, P. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109349840 · Cited by 33
Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population.
Omidinia, E., Mazar, F. M., Shahamati, P., Kianmehr, A., & Shahbazmohammadi, H. (2014) · PubMed Central · Cited by 32
Increased fronto-temporal perfusion in bipolar disorder
Agarwal, N., Bellani, M., Perlini, C., Rambaldelli, G., Atzori, M., Cerini, R., Vecchiato, F., Mucelli, R. P., Andreone, N., Balestrieri, M., et al. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.013 · Cited by 32
Gałecki, P., Gałecka, E., Maes, M. H. J., Orzechowska, A., Berent, D., Talarowska, M. E., Bobińska, K., Lewiñski, A., Bieńkiewicz, M., & Szemraj, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.011 · Cited by 31
Further study of a genetic association between the CLDN5 locus and schizophrenia
Ye, L., Wei, J., Sun, Z., Xie, L. Y., Liu, S., Ju, G., Shi, J., Yu, Y., Zhang, X., Xu, Q., et al. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.11.003 · Cited by 31
Increased levels of serum soluble L-selectin in unmedicated patients with schizophrenia
Iwata, Y., Suzuki, K., Nakamura, K., Matsuzaki, H., Sekine, Y., Tsuchiya, K. J., Sugihara, G., Kawai, M., Minabe, Y., Takei, N., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.026 · Cited by 30
Assessment of cerebral blood volume in schizophrenia: A magnetic resonance imaging study
Brambilla, P., Cerini, R., Fabene, P. F., Andreone, N., Rambaldelli, G., Farace, P., Versace, A., Perlini, C., Pelizza, L., Gasparini, A., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.03.002 · Cited by 28
The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China
Lv, M.-N., Zhang, H., Shu, Y., Chen, S., Hu, Y., & Zhou, M. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0002 · Cited by 28
Brzozowska, N., Smith, K. L., Zhou, C., Waters, P. M., Cavalcante, L. M., Abelev, S. V., Kuligowski, M., Clarke, D. J., Todd, S. M., & Arnold, J. C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.008 · Cited by 28
A weak association of the CLDN5 locus with schizophrenia in Chinese case–control samples
Wu, N., Zhang, X., Jin, S., Liu, S., Ju, G., Wang, Z., Liu, L., Ye, L., & Wei, J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.019 · Cited by 25
Wang, C. S., Yang, Y. K., Chen, M., Chiu, N., Yeh, T. L., & Lee, I. (2003) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70492-9 · Cited by 23
Aboul‐Fotouh, S., & Elgayar, N. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0185 · Cited by 22
Kameno, Y., Iwata, K., Matsuzaki, H., Miyachi, T., Tsuchiya, K. J., Matsumoto, K., Iwata, Y., Suzuki, K., Nakamura, K., Maekawa, M., et al. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-19 · Cited by 22
Pearlman, D. M., Brown, J. R., MacKenzie, T. A., Hernandez, F., & Najjar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111110 · Cited by 19
Wei, J., & Hemmings, G. P. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.08.003 · Cited by 17
Carter, C. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.003 · Cited by 14
Kabakuş, N., Aydın, M., Akın, H., Balcı, T. A., Kurt, A., & Kekilli, E. (2006) · Journal of Child Neurology · doi:10.1177/7010.2006.00230 · Cited by 13
Reduced Capillary Density in the Prefrontal Cortex in Schizophrenia
Uranova, N. A., Zimina, I. S., Vikhreva, O. V., Rachmanova, V. I., Klintsova, A. Y., & Orlovskaya, D. D. (2013) · American Journal of Medical Sciences and Medicine · doi:10.12691/ajmsm-1-3-3 · Cited by 13
Szymanski, S., Ashtari, M., Zito, J. L., Degreef, G., Bogerts, B., & Lieberman, J. A. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90011-e · Cited by 10
Belagodu, A. P., Fleming, S. A., & Galvez, R. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22514 · Cited by 9
Neocortical vasculature abnormalities in the Fragile X mental retardation syndrome
Galvan, A. M., & Galvez, R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.056 · Cited by 7
The Blood-Brain Barrier in Glioblastoma: Pathology and Therapeutic Implications
Kealy, J., & Campbell, M. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46505-0_4 · Cited by 4
Self-citation
Cited by
Claudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
Self-citationXiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17071135 · Cited by 44
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47
Kim, J., Um, H., Kim, N. H., & Kim, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.006 · Cited by 33
Metadata
- Authors
- Kealy, J., Greene, C., & Campbell, M.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 726
- Pages
- 133664
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2810906666
- Cited by
- 307
- References
- 256
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.